Pre-treatment expression data from neoadjuvant platinum & bevacizumab treated triple negative breast cancer patients

Download

Gene expression data from 21 triple negative breast cancer samples treated with cisplatin & bevacizumab in the neoadjuvant setting as part of a clinical trial. Gene expression data RMA normalized was used to find predictors of platinum sensitivity

Cancer Type: Breast Cancer

GPL: 570

Number of Genes with Data: 978

Number Observations: 21

Number Outputs: 1

Imbalanced Ratio: 0.5

Default Task: Classification